Research glossary

A

Accreditation

Formal recognition by an accreditation body that a laboratory is competent to perform specific tests. It is method-specific: a laboratory can be accredited and still perform a given test outside its accredited scope, which is why an accreditation claim is only meaningful with a certificate number and a scope.

Acetate salt

A peptide isolated with acetic acid as the counter-ion. Often preferred over trifluoroacetate for downstream work, and one reason two otherwise identical materials can differ in measured mass per milligram of solid.

Amidation (C-terminal)

A modification in which the C-terminal carboxylic acid is replaced by an amide group. It changes the molecular weight by roughly one dalton and can change the molecule’s behaviour substantially, so it is part of a peptide’s identity, not a detail.

Amino acid analysis (AAA)

A quantitative method in which a peptide is hydrolysed to its constituent amino acids, which are then measured. It is the usual basis for determining net peptide content — how much of a solid is actually peptide.

Analyte

The specific substance a measurement is intended to detect or quantify.

Area percent

The area of one chromatographic peak expressed as a proportion of the total integrated area. The number most often quoted as “purity”; it is a proportion of detected signal, not of mass.

B

Baseline

The detector signal when nothing of interest is eluting. Peak areas are measured relative to it, so where the baseline is drawn directly affects a reported purity figure.

Batch (lot)

A quantity of material produced in a single defined operation and assumed uniform throughout. Testing a sample only describes the batch if the batch is genuinely homogeneous and the sample was representative.

Batch code

The identifier that links a physical container to production and testing records. Formats are not standardised and cannot be decoded from outside; a code is a pointer to records, not evidence in itself.

Blank injection

A run in which solvent alone is injected, used to show that observed peaks come from the sample rather than from the system, the solvent or carry-over from a previous injection.

C

Calibration

Establishing the relationship between an instrument’s response and known quantities of a reference material. Quantitative results depend on it; relative measures such as area percent do not.

Capillary electrophoresis (CE)

A separation technique that sorts species by their movement in an electric field. Used for peptides as an orthogonal check on chromatographic results and for counter-ion determination.

Certificate of analysis (COA)

A laboratory report stating what sample was received, what methods were applied and what results were obtained. It describes one sample at one moment and is not an approval, a licence or a guarantee.

Chain of custody

The documented history of a sample: who held it, when, and under what conditions. It is what allows a result on a sample to be attributed to a batch.

Chromatogram

The plot of detector response against time produced by a chromatographic run. It shows when things eluted, not what they were.

Co-elution

Two or more components leaving the column at the same time and being integrated as one peak. The main reason a single sharp peak is evidence of homogeneity rather than proof of a single compound.

Column

The packed tube in which chromatographic separation happens. Its dimensions, packing chemistry and particle size are part of the method and affect what a run can resolve.

Counter-ion

The ion accompanying a charged peptide in the solid state, typically from the acid used during purification. It contributes to the weight of the solid without being part of the peptide.

Crude peptide

The material obtained directly after synthesis and cleavage, before purification. Always a mixture of the target peptide and process-related impurities.

Cyclisation

Formation of a ring within a peptide, for example by a disulfide bridge or a head-to-tail bond. Cyclic and linear forms of the same sequence are different molecules and can share the same nominal mass.

D

Dalton (Da)

The unit used for molecular mass. A single dalton difference is routinely meaningful for peptides — it can distinguish an amide from an acid, or a deamidated species from an intact one.

D-amino acid

The mirror-image form of a standard L-amino acid. Substituting one changes the molecule’s three-dimensional shape and behaviour while leaving the mass unchanged, so mass spectrometry alone cannot detect it.

Deamidation

A degradation reaction converting asparagine or glutamine side chains to acidic residues, changing mass by about one dalton and typically producing a new, closely eluting peak.

Deletion sequence

An impurity in which one residue failed to couple during synthesis, leaving a chain one residue short. A characteristic and expected process-related impurity.

Detection wavelength

The wavelength at which a UV detector monitors the column outlet — commonly near 214–220 nm for the peptide bond, or 280 nm for aromatic residues. Purity figures obtained at different wavelengths are not directly comparable.

E

Electrospray ionisation (ESI)

The standard method of getting peptides into a mass spectrometer from a liquid stream. It tends to produce multiply charged ions, so one molecule can appear at several mass-to-charge values.

Elution

The emergence of a component from the column, carried by the mobile phase.

Endotoxin testing

Measurement of bacterial endotoxin, usually by an LAL assay. Entirely separate from purity and identity: a chemically pure material can carry endotoxin, and a certificate silent on it says nothing either way.

F

Flow rate

The volume of mobile phase pumped through the column per minute. Part of the method, and one of several parameters that shift retention times between laboratories.

Fmoc chemistry

The base-labile protecting-group strategy used in most modern solid-phase peptide synthesis, named after the fluorenylmethyloxycarbonyl group.

Free acid

A peptide whose C-terminus is an unmodified carboxylic acid, as distinct from an amidated C-terminus.

G

Good Laboratory Practice (GLP)

A quality framework for non-clinical studies, concerned with how data are generated, recorded and retained so that a result can be reconstructed later. Most research-grade chemical supply does not operate under it.

Gradient

A programmed change in mobile-phase composition during a run, used to separate components with a wide range of retention behaviour. Different gradients produce different retention times and can change apparent purity.

H

Homogeneity

Uniformity of composition. Chromatographic homogeneity — one clean peak — is what an HPLC purity figure measures; it is weaker than proof of a single chemical species.

HPLC

High-performance liquid chromatography: separation of a mixture by passing it dissolved in a liquid through a packed column at high pressure. The routine method for peptide purity assessment.

I

Identity testing

Testing intended to establish that a substance is the compound claimed, typically by confirming molecular mass and, more rigorously, sequence. Distinct from purity testing.

Impurity (process-related)

A species arising from the manufacturing process rather than from degradation — truncated chains, incompletely deprotected chains, side-reaction products and residual reagents.

Injection volume

The amount of sample introduced onto the column. Too much can distort peak shape and integration; it is part of a properly reported method.

Integration

The software-assisted, operator-supervised process of defining peak boundaries and computing areas. A judgement step that can move a reported purity figure without anything being falsified.

Ion chromatography

A chromatographic method for measuring ionic species, used on peptide products mainly to quantify counter-ions such as trifluoroacetate.

Isobar

Two different species with effectively the same mass. Mass spectrometry cannot distinguish them, which is why a matching mass is consistency rather than proof.

Isomer

Compounds with the same molecular formula but different structure — including sequence isomers, stereoisomers and disulfide-scrambled forms. Same mass, different molecule.

K

Karl Fischer titration

A precise chemical method for determining water content. Relevant because residual water contributes to the weight of a lyophilised solid without being peptide.

L

LC-MS

Liquid chromatography coupled to mass spectrometry. Separates a mixture and then measures the mass of what elutes, which is why it is the standard combined identity-and-purity technique.

Limit of detection (LOD)

The smallest amount of an analyte a method can reliably distinguish from background. Impurities below it are undetected, not absent.

Limit of quantitation (LOQ)

The smallest amount that can be measured with acceptable precision. Between the LOD and the LOQ, a substance can be seen but not reliably quantified.

Loss on drying

A gravimetric measure of volatile content, obtained by weighing a sample before and after drying. A simpler alternative to Karl Fischer titration for water content.

Lyophilisation

Freeze-drying: removal of water by sublimation under vacuum, leaving a dry solid. The usual final step in preparing a synthetic peptide.

M

Mass spectrometry (MS)

Measurement of ions sorted by mass-to-charge ratio. Confirms molecular mass, and with fragmentation can support sequence claims.

Method validation

Documented evidence that an analytical procedure is fit for its intended purpose — covering specificity, accuracy, precision, range and robustness. What separates a validated result from a plausible one.

Mobile phase

The liquid that carries the sample through the column. For peptides typically water and acetonitrile with an acidic modifier; its composition is part of the method.

Molecular weight (average vs monoisotopic)

Average molecular weight uses the natural abundance-weighted mass of each element; monoisotopic mass uses the lightest isotope of each. Reports and calculations must compare like with like, since the two differ measurably for peptides.

MS/MS (tandem mass spectrometry)

Fragmenting a selected ion and measuring the fragments, which can confirm the order of residues rather than only the total mass. Comparatively rare on commercial certificates.

N

Net peptide content

The proportion of a solid that is peptide, as opposed to water, salts and counter-ions — usually determined by amino acid analysis. Answers “how much peptide is here”, which chromatographic purity does not.

NMR spectroscopy

Nuclear magnetic resonance spectroscopy: a structural technique that can resolve questions about connectivity and, in some cases, stereochemistry that mass measurement cannot.

O

Orthogonal method

A second method that separates or detects on a different physical principle from the first. Agreement between orthogonal methods is much stronger evidence than a repeated run of the same one.

Oxidation

A degradation route affecting methionine, cysteine and tryptophan residues in particular, adding mass and often producing new chromatographic peaks.

P

Peak

A localised rise in detector signal, corresponding to something eluting from the column. Its position suggests what it might be; its area indicates how much signal it produced.

Peak purity

An assessment of whether a single peak represents a single component, for example by comparing spectra across the peak. Stronger evidence than peak shape alone, and not the same thing as an area-percent purity figure.

Peptide bond

The amide linkage joining one amino acid to the next, formed with the loss of water. It absorbs ultraviolet light near 214 nm, which is why that wavelength is used for peptide detection.

Purity

The proportion of a material that is the intended substance. Always qualified by the method: chromatographic purity, purity by mass and net peptide content are different measurements.

Q

Quality control (QC) sample

A sample of known composition analysed alongside unknowns to demonstrate that the method performed as expected during that run.

R

Reference standard

A well-characterised sample of the target compound used for comparison. Without one, a retention time is a fingerprint with nothing to match it against.

Related substance

An impurity structurally related to the target compound — a truncated, modified or degraded form. Their presence in a synthetic peptide report is expected rather than alarming.

Reproducibility

Agreement between results obtained under changed conditions — different operator, instrument, day or laboratory. Distinct from repeatability, which is agreement within one set of conditions.

Research use only (RUO)

A labelling designation indicating that a material is supplied for laboratory research and not for diagnostic, clinical, human or veterinary use. It is a restriction, not a quality grade.

Residual solvent

Solvent remaining from synthesis or purification, usually determined by headspace gas chromatography. Invisible to UV-based purity measurement.

Resolution

A measure of how completely two adjacent peaks are separated. Poor resolution means integration boundaries — and therefore purity figures — become uncertain.

Retention time

The time between injection and a component eluting. Characteristic under fixed conditions, but not transferable between methods or laboratories without a shared reference standard.

Reverse-phase chromatography

Chromatography with a non-polar stationary phase and a polar mobile phase, the standard configuration for peptide separation.

S

Salt form

Which acid or base a compound was isolated with. It affects the weight of the solid and its measured mass per milligram without altering the peptide itself.

Sample identity

The fields on a report that state what was tested — laboratory sample ID, material name, batch code and description as received. The link between a document and a physical object.

Sequence

The order of amino acid residues in a peptide, conventionally written N-terminus to C-terminus. Together with terminal chemistry and modifications, it defines the molecule.

Signal-to-noise ratio

The size of a signal relative to background noise. It sets what can be detected and is a common reason small impurity peaks are not reported.

Solid-phase peptide synthesis (SPPS)

Synthesis of a peptide on an insoluble resin support, adding residues in cycles. Introduced by Merrifield in 1963 and the basis of most synthetic peptide production.

Solvent front

The early signal from unretained material at the start of a run. Normally excluded from purity calculations, and a report should make clear what was integrated.

Specification

The acceptance criterion a result is judged against, for example “≥98.0%”. A specification quoted where a result belongs tells you what was wanted, not what was found.

Stability

How a material’s composition changes over time under given conditions. It is why a test result carries a date and why an old report is a historical statement.

Stationary phase

The material packed inside the column with which sample components interact. Its chemistry determines the separation.

T

Third-party testing

Testing by a laboratory independent of the party making the claim. Its strength depends on the laboratory being named, the test falling within an accredited scope, and the sample being traceable to a batch.

Trifluoroacetate (TFA)

A counter-ion very commonly present after reverse-phase purification with trifluoroacetic acid. It adds weight to the solid, is not detected by typical UV purity methods, and is sometimes exchanged for acetate.

U

UV detection

Measurement of ultraviolet absorbance at the column outlet. It only sees species that absorb at the chosen wavelength, so salts and many process residues are effectively invisible to it.

V

Void volume

The volume of mobile phase needed to pass an unretained component through the system. Sets the earliest possible retention time and marks the solvent front.

W

Water content

Residual moisture in a solid, determined by Karl Fischer titration or loss on drying. Part of the weight of the material and entirely separate from purity or identity.